Results for tag: "Lonidamine"

Lonidamine is an oncology drug used to treat certain types of cancer. It is a small molecule inhibitor of the enzyme hexokinase, which is involved in the metabolism of glucose. Lonidamine has been used in combination with other drugs to treat a variety of cancers, including breast, ovarian, and lung cancer. It has also been used to treat metastatic melanoma. Lonidamine has been shown to be effective in reducing tumor size and improving survival rates in some patients. Lonidamine is available in both oral and intravenous formulations. It is typically administered in combination with other drugs, such as chemotherapy or radiation therapy. The drug is generally well tolerated, with few side effects. The lonidamine market is a growing one, with a number of companies offering products. These include Merck, Pfizer, Novartis, and AstraZeneca. Other companies, such as Bristol-Myers Squibb, are also involved in the development of lonidamine-based treatments. Show Less Read more